Author

Jyoti Raychaudhuri

Observed name: J. Raychaudhury

Institutions: University of South Florida, Moffitt Cancer Center

Observed institutions: University of South Florida, Moffitt Cancer Center

OpenAlex ID: A5113787168

Fludarabine and Pharmacokinetic-Targeted Busulfan before Allografting for Adults with Acute Lymphoid Leukemia

2011 · Stella Santarone, Joseph Pidala, et al. · Transplantation and Cellular Therapy · 35

Bortezomib salvage followed by a P hase I / II study of bortezomib plus high‐dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma

2012 · Taiga Nishihori, Todd J. Alekshun, et al. · British Journal of Haematology · 23

Phase I Study of Bortezomib, (BTZ) Followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL).

2007 · Todd Alekshun, Christine Mcisaac-Simonelli, et al. · Blood · 2

Autologous Stem Cell Transplantation (ASCT) In Patients Aged ≥65 Years With Multiple Myeloma: Moffitt Cancer Center Experience

2009 · C. Paoletti, L. Balducci, et al. · Transplantation and Cellular Therapy

Allogeneic Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) after Pretransplant 5-Azacitidine.

2007 · Teresa Field, Melissa Alsina, et al. · Blood

Phase I/II Trial of High-Dose Melphalan (M) and Topotecan (T) Followed by Autologous Stem Cell Rescue in Patients ≤ 60 and > 60 Years of Age with Multiple Myeloma (MM).

2007 · Daniel Sullivan, Melissa Alsina, et al. · Blood

Works count: 6

Citation count: 60

H-index: 2

I10-index: 2